Whitney Economics Estimates US Cannabis Production Surpasses 48.8 Million Pounds

Dec.09.2022
Whitney Economics Estimates US Cannabis Production Surpasses 48.8 Million Pounds
Whitney Economics predicts US cannabis sales will reach $29.3 billion by 2022 and $81.6 billion by 2030.

According to a new report by Whitney Economics, the total production of marijuana in the United States exceeds 48.8 million pounds.


The data included in the "2022 US Marijuana Supply Report" covers both legal and illegal markets and spans all product types, such as flowers, concentrates, and edibles.


Beau Whitney, founder and chief economist of Whitney Economics, has stated that the total supply has slightly increased compared to 2021. He added that the supply and demand are well balanced this year.


Whitney stated that some growers in Northern California and Southern Oregon had successful harvests and planted more crops, "but the typical practice is if they have an oversupply one year, they will not plant as much the following year. This has been confirmed through my interviews in legacy fields and with regulatory agencies in multiple states.


According to Whitney Economics, the total sales of legal marijuana are expected to reach $29.3 billion by 2022 and $81.6 billion by 2030. The company also predicts that starting in 2026, the legal supply will surpass the illegal supply.


Related: These eight states sold $12.8 billion in adult-use cannabis in 2021.


Whitney stated that if the current legal cultivation capacity in the United States reached 100%, it would be approximately 1.5 times the total demand for cannabis in the country.


Whitney stated that some believe "unlimited demand, unlimited permission - this is the best option," but Whitney Economics strongly opposes this view. While it may be applicable to a national market, in the current context of isolated systems within individual countries, it can easily lead to overproduction and a surplus of supply compared to demand.


Michigan serves as a perfect example of the current state of the marijuana industry in states like Oregon, Colorado, and California. With supply outweighing demand, prices are being driven down, resulting in cutthroat competition that harms small businesses, women-owned businesses, and minority-owned businesses, ultimately squeezing out profits. However, multi-state operators (MSOs) are benefiting from this situation as they have the resources to sustain fierce competition and acquire necessary funds.


Whitney Economics has proposed to regulatory agencies an annual adjustment of supply capacity based on the schedule of each project, according to Whitney.


By avoiding the risk of oversupply, this creates a healthier, stronger, and more successful market," stated Whitney. "The purpose of this approach is to encourage consumers to enter the legal market because the prices are reasonable, without causing operators to fail. Therefore, it is a modified limited licensing model rather than an arbitrary one. The countries we have been discussing this with are very interested in learning more about the model.


Whitney stated that the state of Illinois is an example of a state that could benefit from more licenses. "They do have limited licenses there and they just need more. They need more supply, they need more opportunities," he said. "They limit the amount of retail stores so consumers don't have as much access. They just say, 'Well, I'm not going to drive 30, 40, 50 minutes to get marijuana when I can get it quicker through illegal channels.'


Therefore, our recommendation for the state of Illinois is to increase supply capacity and the number of retail stores, in order to make the produced supply more accessible to a larger number of consumers.


According to Whitney, the growth projections outlined in the new report assume that states with medical or adult-use programs will increase to meet the demands of consumers and patients. Additionally, cannabis will become more normalized, either through federal legalization or interstate commerce.


He said that inflation may affect the future supply and demand of marijuana and has already started to impact the decline of consumer behavior.


Furthermore, due to oversupply in many of these states, prices are decreasing. As a result, retailers may sell the same amount of marijuana but at a cheaper price. The amount consumers are spending now is not entirely the same," Whitney said.


But where inflation really hits the cannabis industry is in the startup costs," he said. These costs include facility construction, PVC piping, HVAC systems, and more.


According to Whitney, in mature markets, people are buying existing businesses instead of creating new ones, so inflation won't play a role in the building industry's inflation. However, in new markets like future New York, New Jersey, Maryland, Missouri, and Pennsylvania- states with high populations- the growth rate of the entire market is significant. These markets might restrain sales, not because demand is absent, but because supply is scarce, and operators have a difficult time starting up.


Related: The decrease in marijuana prices exacerbates inflation in the market.


Whitney stated that the future that the industry needs is a transition from independent supply chains in each state to allowing marijuana businesses across the country to collaborate legally and compliantly.


At the federal level, there is a compelling case being made for some more prominent issues, particularly with regard to the SAFE Banking Act, interstate commerce, and tax reform under Section 280E - all of which impact the industry," Whitney stated.


2FIRSTS will continue to track and report on this issue. Further updates will be available on the "2FIRSTS APP." Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

 Number of Vapers in Britain Surpasses Smokers for the First Time, Government Tightens Nicotine Regulations
Number of Vapers in Britain Surpasses Smokers for the First Time, Government Tightens Nicotine Regulations
For the first time, more people in Britain now vape than smoke. According to the Office for National Statistics (ONS), 10% of adults (5.4 million) regularly use e-cigarettes compared with 9.1% (4.9 million) who smoke cigarettes. The government credits vaping for the decline in smoking but plans tougher rules through the Tobacco and Vapes Bill, including a generational smoking ban and restrictions on nicotine pouch flavours, packaging, and sales.
Nov.05 by 2FIRSTS.ai
ITGA 与 2Firsts 签署战略合作备忘录,共同支持全球烟草种植者
ITGA 与 2Firsts 签署战略合作备忘录,共同支持全球烟草种植者
ITGA Annual General Meeting 2025 held in Germany alongside InterTabac/InterSupply 2025 showcases global tobacco supply chain opportunities.
Sep.23 by 2FIRSTS.ai
InterTabac 2025|Interview with Mylor Innovation Lab: Flavor Innovation × Compliance First, From Redefining Sourness to Global Expansion
InterTabac 2025|Interview with Mylor Innovation Lab: Flavor Innovation × Compliance First, From Redefining Sourness to Global Expansion
At InterTabac 2025, Mylor Innovation Lab launched its JuiSour series of sourness solutions, attracting clients across Europe, the Middle East, etc. The JuiSour series enhance aroma and juiciness, and improve sour-sweet balance by reformulating the flavor, customizing the formulation and using a “Golden Sour-Sweet Ratio” model . Mylor emphasizes compliance and foresees two key trends “compliance-driven growth” and “flavor segmentation”, helping partners stand out in a homogenized global market.
Sep.19
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
US FDA meeting minutes: Under Trump, a new pilot eases nicotine pouch rules—cuts product-specific research (uses generic data), shortens reviews, boosts communication. It’s the FDA’s first clear softer stance on smoking alternatives. The pilot may benefit Philip Morris (Zyn), Altria (On!), BAT (Velo) but sparks debate: FDA says pouches are low-risk (no youth surge), while ex-officials/academics cite missing research (hurts health checks, risks hidden youth use). Firms note costly research remain
Sep.19 by 2FIRSTS.ai
JTI launches Ploom AURA new heated tobacco device device in Romania
JTI launches Ploom AURA new heated tobacco device device in Romania
Japan Tobacco International(JTI) introduces Ploom AURA in Romania, combining SMART HEATFLOW technology to preserve tobacco flavor, aiming at high-end consumers.
Oct.17 by 2FIRSTS.ai
US study finds nicotine pouches may help tobacco users quit, but safety remains to be determined
US study finds nicotine pouches may help tobacco users quit, but safety remains to be determined
A recent US study found those who recently quit smoking are 3.9 times more likely to use nicotine pouches.
Sep.17 by 2FIRSTS.ai